Determinants of perception of heartburn and regurgitation.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMC 1856084)

Published in Gut on August 24, 2005

Authors

A J Bredenoord1, B L A M Weusten, W L Curvers, R Timmer, A J P M Smout

Author Affiliations

1: Department of Gastroenterology, St Antonius Hospital, PO Box 2500, 3430 EM Nieuwegein, and Gastrointestinal Research Centre, University Medical Centre, Utrecht, the Netherlands. a.bredenoord@antonius.net

Articles citing this

High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology (2008) 1.51

When proton pump inhibitors fail. Clin Gastroenterol Hepatol (2008) 1.45

Symptomatic reflux disease: the present, the past and the future. Gut (2014) 1.29

Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease. Gut Liver (2009) 1.21

Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04

Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One (2014) 0.97

Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux. Neurogastroenterol Motil (2015) 0.96

Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc (2013) 0.93

Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci (2010) 0.93

Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol (2011) 0.91

Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa. Am J Physiol Gastrointest Liver Physiol (2015) 0.90

Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data. J Clin Gastroenterol (2015) 0.86

The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring. Dig Dis Sci (2010) 0.85

Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease. World J Gastroenterol (2014) 0.85

Advances in motility testing--current and novel approaches. Nat Rev Gastroenterol Hepatol (2013) 0.85

Current advances in the diagnosis and treatment of nonerosive reflux disease. Gastroenterol Res Pract (2013) 0.83

Electrophysiological characterization of vagal afferents relevant to mucosal nociception in the rat upper oesophagus. J Physiol (2007) 0.83

Management of the patient with incomplete response to PPI therapy. Best Pract Res Clin Gastroenterol (2013) 0.82

Symptomatic gastro-oesophageal reflux in a patient with achlorhydria. Gut (2006) 0.81

Role of non-acid reflux in patients with non-erosive reflux disease. Ann Gastroenterol (2013) 0.80

Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium. Int J Cancer (2015) 0.79

Diagnosis of Gastroesophageal Reflux Disease Using Real-time Magnetic Resonance Imaging. Sci Rep (2015) 0.79

Republished: symptomatic reflux disease: the present, the past and the future. Postgrad Med J (2015) 0.78

Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats. Biomol Ther (Seoul) (2014) 0.78

Role of Acid and weakly acidic reflux in gastroesophageal reflux disease off proton pump inhibitor therapy. J Neurogastroenterol Motil (2012) 0.76

Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24- hour Esophageal Impedance and pH Monitoring. J Neurogastroenterol Motil (2016) 0.75

Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients. World J Gastroenterol (2015) 0.75

Esophageal Submucosal Injection of Capsaicin but Not Acid Induces Symptoms in Normal Subjects. J Neurogastroenterol Motil (2016) 0.75

Generation of Gastroesophageal Reflux Disease Symptoms During Esophageal Acid Infusion With Concomitant Esophageal pH Monitoring in Healthy Adults. J Neurogastroenterol Motil (2013) 0.75

Critical analysis of esophageal multichannel intraluminal impedance monitoring 20 years later. ISRN Gastroenterol (2012) 0.75

Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus. Br J Cancer (2016) 0.75

Brain activity following esophageal acid infusion using positron emission tomography. World J Gastroenterol (2010) 0.75

In GERD patients, mucosal repair associated genes are upregulated in non-inflamed oesophageal epithelium. J Cell Mol Med (2008) 0.75

Discounting the duration of bolus exposure in impedance testing underestimates acid reflux. BMC Gastroenterol (2016) 0.75

Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. Nat Rev Gastroenterol Hepatol (2016) 0.75

Articles cited by this

Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut (2004) 3.85

Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology (2001) 3.35

Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med (1984) 2.68

Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut (1999) 2.48

Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology (2001) 2.41

Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial. Gastroenterology (1978) 2.21

Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut (2005) 2.20

Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology (1998) 1.70

Relevance of ineffective oesophageal motility during oesophageal acid clearance. Gut (2003) 1.61

Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol (2004) 1.56

Functional heartburn: the stimulus, the pain, and the brain. Gut (2002) 1.51

What is the optimal time window in symptom analysis of 24-hour esophageal pressure and pH data? Dig Dis Sci (1994) 1.45

Effect of sleep on swallowing, esophageal peristalsis, and acid clearance. Gastroenterology (1984) 1.41

Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci (1989) 1.30

Effect of cimetidine in symptomatic gastro-oesophageal reflux. Lancet (1978) 1.24

Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2003) 1.22

Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease. Gut (1994) 1.21

Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease. Gut (1991) 1.17

Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology (1995) 1.17

Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux. Gut (2005) 1.07

Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol (2005) 1.07

Relevance of volume and proximal extent of reflux in gastro-oesophageal reflux disease. Gut (2005) 1.01

Oesophageal wall stretch: the stimulus for distension induced oesophageal sensation. Neurogastroenterol Motil (2004) 0.97

Measuring esophageal distention by high-frequency intraluminal ultrasound probe. Am J Med (2003) 0.94

Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain. J Clin Gastroenterol (2000) 0.92

Dynamic characteristic of gastro-oesophageal reflux in ambulatory patients with gastro-oesophageal reflux disease and normal control subjects. Scand J Gastroenterol (1995) 0.90

Sensitization of esophageal mucosa by prior acid infusion: effect of decreasing intervals between infusions. Am J Gastroenterol (1996) 0.88

Minimum sample frequency for multichannel intraluminal impedance measurement of the oesophagus. Neurogastroenterol Motil (2004) 0.88

PAIN DUE TO ESOPHAGEAL DISTENTION. Am J Dig Dis (1963) 0.84

Articles by these authors

Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24

The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69

Nurse endoscopists perform colonoscopies according to the international standard and with high patient satisfaction. Endoscopy (2012) 3.27

Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study. Endoscopy (2013) 2.76

Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut (2010) 2.25

Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2006) 2.07

Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med (1996) 2.00

Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol (2011) 1.91

Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg (2010) 1.85

Learning to perform endoscopic resection of esophageal neoplasia is associated with significant complications even within a structured training program. Endoscopy (2011) 1.82

PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil (2012) 1.80

Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy (2008) 1.71

Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy (2008) 1.71

Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. Am J Gastroenterol (2010) 1.58

Prevalence of esophageal disorders in patients with chest pain newly referred to the cardiologist. Chest (1996) 1.50

Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy (2008) 1.48

Objective definition and detection of transient lower esophageal sphincter relaxation revisited: is there room for improvement? Neurogastroenterol Motil (2011) 1.46

Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut (2004) 1.43

Epidemiological, clinical, and histological characteristics of intestinal metaplasia at the oesophagogastric junction compared to short segments of columnar-lined oesophagus. Eur J Gastroenterol Hepatol (2001) 1.43

Predictors of objectively identified recurrent reflux after primary Nissen fundoplication. Br J Surg (2011) 1.42

Prospective feasibility study on the use of multiband mucosectomy for endoscopic resection of early squamous neoplasia in the esophagus. Endoscopy (2012) 1.40

[Oesophageal endoscopic ultrasound with fine-needle aspiration biopsy in the staging of non-small-cell lung carcinoma; results from 43 patients]. Ned Tijdschr Geneeskd (2006) 1.39

[Therapy-resistant gastro-oesophageal reflux disease: endoluminal treatment not yet sufficiently compared with the gold standard, the laparoscopic Nissen fundoplication]. Ned Tijdschr Geneeskd (2008) 1.38

Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care (2003) 1.34

Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut (2005) 1.29

Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut (2006) 1.28

Normal values for solid-state esophageal high-resolution manometry in a European population; an overview of all current metrics. Neurogastroenterol Motil (2014) 1.24

Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil (2012) 1.22

Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? Eur J Nucl Med Mol Imaging (2014) 1.19

Occurrence of esophageal granular cell tumors in The Netherlands between 1988 and 1994. Dig Dis Sci (2001) 1.16

Stent-in-stent technique for removal of embedded esophageal self-expanding metal stents. Am J Gastroenterol (2010) 1.16

Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study. Endoscopy (2011) 1.13

Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.09

Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy (2013) 1.09

Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus. Endoscopy (2011) 1.09

Assessment of oesophageal motor function using combined perfusion manometry and multi-channel intra-luminal impedance measurement in normal subjects. Neurogastroenterol Motil (2005) 1.05

The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther (2002) 1.04

Reproducibility of esophageal high-resolution manometry. Neurogastroenterol Motil (2011) 1.04

Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus (2008) 1.03

Normal values for esophageal high-resolution manometry. Neurogastroenterol Motil (2013) 1.02

Elicitation of transient lower oesophageal sphincter relaxations in response to gastric distension and meal ingestion. Neurogastroenterol Motil (2002) 1.00

The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther (2002) 0.99

Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy (2010) 0.99

Double-peaked high-pressure zone at the esophagogastric junction in controls and in patients with a hiatal hernia: a study using high-resolution manometry. Dig Dis Sci (2004) 0.98

Effects of adjustable gastric banding on gastroesophageal reflux and esophageal motility: a systematic review. Obes Rev (2009) 0.96

Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3). Am J Gastroenterol (2009) 0.95

Colorectal visceral perception in diverticular disease. Gut (2004) 0.95

Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2009) 0.95

Laparoscopic Nissen fundoplication after failed EsophyX fundoplication. Br J Surg (2010) 0.95

Normative values in esophageal high-resolution manometry. Neurogastroenterol Motil (2014) 0.94

Long-term effect of fundoplication on motility of the oesophagus and oesophagogastric junction. Br J Surg (2004) 0.94

Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome. Dig Dis Sci (2003) 0.93

Video capsule endoscopy: procedure, indications and diagnostic yield. Neth J Med (2004) 0.92

Assessment of oesophageal emptying in achalasia patients by intraluminal impedance monitoring. Neurogastroenterol Motil (2006) 0.92

Sensation of stasis is poorly correlated with impaired esophageal bolus transport. Neurogastroenterol Motil (2013) 0.91

High-resolution manometry. Dig Liver Dis (2007) 0.91

Relationship between esophageal contraction patterns and clearance of swallowed liquid and solid boluses in healthy controls and patients with dysphagia. Neurogastroenterol Motil (2012) 0.90

Sleeve sensor versus high-resolution manometry for the detection of transient lower esophageal sphincter relaxations. Am J Physiol Gastrointest Liver Physiol (2005) 0.90

Relationships between air swallowing, intragastric air, belching and gastro-oesophageal reflux. Neurogastroenterol Motil (2005) 0.90

Speech therapy in patients with excessive supragastric belching--a pilot study. Neurogastroenterol Motil (2009) 0.89

Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut (2007) 0.89

The effect of endoscopic mucosal resection and transanal endoscopic microsurgery on anorectal function. Colorectal Dis (2013) 0.89

Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterol Motil (2009) 0.88

Minimum sample frequency for multichannel intraluminal impedance measurement of the oesophagus. Neurogastroenterol Motil (2004) 0.88

Electrical tissue impedance spectroscopy: a novel device to measure esophageal mucosal integrity changes during endoscopy. Neurogastroenterol Motil (2013) 0.87

Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2012) 0.87

Relationships between gastric accommodation and gastrointestinal sensations in healthy volunteers. A study using the barostat technique and two- and three-dimensional ultrasonography. Dig Dis Sci (2005) 0.87

Weight loss after laparoscopic adjustable gastric banding is not caused by altered gastric emptying. Obes Surg (2008) 0.87

Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia. Aliment Pharmacol Ther (2007) 0.87

In search of objective manometric criteria for colonic high-amplitude propagated pressure waves. Neurogastroenterol Motil (2002) 0.87

Routine colonoscopy is not required in uncomplicated diverticulitis: a systematic review. Surg Endosc (2014) 0.87

The gastro-oesophageal common cavity revisited. Neurogastroenterol Motil (2006) 0.87

Interdigestive transpyloric fluid transport assessed by intraluminal impedance recording. Am J Physiol Gastrointest Liver Physiol (2002) 0.86

Mechanisms of gastric and supragastric belching: a study using concurrent high-resolution manometry and impedance monitoring. Neurogastroenterol Motil (2012) 0.86

[Belching (ructus)]. Ned Tijdschr Geneeskd (2006) 0.85

Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neurogastroenterol Motil (2014) 0.85

Diagnostic value of the Reflux Disease Questionnaire in general practice. Digestion (2007) 0.85

Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands. Aliment Pharmacol Ther (2008) 0.85

Accuracy of hiatal hernia detection with esophageal high-resolution manometry. Neurogastroenterol Motil (2015) 0.85

Fully automated analysis of colonic manometry recordings. Neurogastroenterol Motil (2002) 0.84

Endoscopic cap resection for treatment of early Barrett's neoplasia is safe: a prospective analysis of acute and early complications in 216 procedures. Dis Esophagus (2007) 0.84

Third-generation autofluorescence endoscopy for the detection of early neoplasia in Barrett's esophagus: a pilot study. Dis Esophagus (2013) 0.83

Role of chemical stimulation of the duodenum in dyspeptic symptom generation. Am J Gastroenterol (2010) 0.83